Filter
Reset all

Subjects

Content Types

Countries

AID systems

API

Data access

Data access restrictions

Database access

Database access restrictions

Database licenses

Data licenses

Data upload

Data upload restrictions

Enhanced publication

Institution responsibility type

Institution type

Keywords

Metadata standards

PID systems

Provider types

Quality management

Repository languages

Software

Syndications

Repository types

Versioning

  • * at the end of a keyword allows wildcard searches
  • " quotes can be used for searching phrases
  • + represents an AND search (default)
  • | represents an OR search
  • - represents a NOT operation
  • ( and ) implies priority
  • ~N after a word specifies the desired edit distance (fuzziness)
  • ~N after a phrase specifies the desired slop amount
  • 1 (current)
Found 7 result(s)

Alzheimer's Disease Neuroimaging Initiative Image and Data Archive

ADNI Image and Data Archive

Subject(s)
Content type(s)
Country
All ADNI data are shared without embargo through the LONI Image and Data Archive (IDA), a secure research data repository. Interested scientists may obtain access to ADNI imaging, clinical, genomic, and biomarker data for the purposes of scientific investigation, teaching, or planning clinical research studies. "The Alzheimer’s Disease Neuroimaging Initiative (ADNI) unites researchers with study data as they work to define the progression of Alzheimer’s disease (AD). ADNI researchers collect, validate and utilize data, including MRI and PET images, genetics, cognitive tests, CSF and blood biomarkers as predictors of the disease. Study resources and data from the North American ADNI study are available through this website, including Alzheimer’s disease patients, mild cognitive impairment subjects, and elderly controls. "

SumsDB

Surface management system database

Subject(s)
Content type(s)
Country
<<!! checked 20.03.2017 SumsDB was offline; for more information and archive see http://brainvis.wustl.edu/sumsdb/ >> SumsDB (the Surface Management System DataBase) is a repository of brain-mapping data (surfaces & volumes; structural & functional data) from many laboratories.

Brain-CODE

Brain-Centre for Ontario Data Exploration

Subject(s)
Content type(s)
Country
Brain-CODE is a large-scale informatics platform that manages the acquisition and storage of multidimensional data collected from participants with a variety of brain disorders.

Open Rotterdam Glaucoma Imaging Data Sets

ORGIDS

Subject(s)
Content type(s)
Country
***<<<!!!>>> *** Stated 2017-08-28: To accommodate a wider scope of ophthalmic data, we launched our new Rotterdam Ophthalmic Data Repository. Please visit http://www.rodrep.com/ for all data sets. *** The ORGIDS site will no longer be updated! ***<<<!!!>>>***Through this portal, we will make data sets available that result from our glaucoma research. This includes visual fields, various imaging modalities and other data from both glaucomatous and normal subjects.The data was acquired during more than a decade.

NeuroMorpho.Org

NeuroMorpho

Subject(s)
Content type(s)
Country
NeuroMorpho.Org is a centrally curated inventory of digitally reconstructed neurons associated with peer-reviewed publications. It contains contributions from over 80 laboratories worldwide and is continuously updated as new morphological reconstructions are collected, published, and shared. To date, NeuroMorpho.Org is the largest collection of publicly accessible 3D neuronal reconstructions and associated metadata which can be used for detailed single cell simulations.

PRO-ACT

Pooled Resource Open-Access ALS Clinical Trials Database

Subject(s)
Content type(s)
Country
The PRO-ACT platform houses the largest ALS clinical trials dataset ever created. It is a powerful tool for biomedical researchers, statisticians, clinicians, or anyone else interested in "Big Data." PRO-ACT merges data from existing public and private clinical trials, generating an invaluable resource for the design of future ALS clinical trials. The database will also contribute to the identification of unique observations, novel correlations, and patterns of ALS disease progression, as well as a variety of still unconsidered analyses. More than 600,000 people around them world are battling ALS. The disease strikes indiscriminately, and typically patients will die within 2-5 years following diagnosis. Currently, there are no effective treatments or a cure for ALS. Users of PRO-ACT are helping to accelerate the discovery, development, and delivery of ALS treatments, which will provide hope to patients and their families.

eyeMoviePedia

Subject(s)
Content type(s)
Country
>>>!!!<<< eyemoviepedia.com was shut down in the course of 2021 https://www.zbmed.de/en/research/completed-projects/eyemoviepedia/ >>>!!!<<< The eyeMoviePedia videos moved successively to be found on PUBLISSO-Repository for Life Sciences (FRL) in the future. https://www.re3data.org/repository/r3d100013523 To view the new eyeMoviePedia collection see: https://repository.publisso.de/resource?query[0][term]=%22https%3A%2F%2Fd-nb.info%2Fgnd%2F1223212661%22